loadpatents
name:-0.01578688621521
name:-0.017784118652344
name:-0.0038511753082275
Deignan; Jeffrey Patent Filings

Deignan; Jeffrey

Patent Applications and Registrations

Patent applications and USPTO patent grants for Deignan; Jeffrey.The latest application filed is for "piperidinone derivatives as mdm2 inhibitors for the treatment of cancer".

Company Profile
5.20.24
  • Deignan; Jeffrey - San Francisco CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20220169611 - Bartberger; Michael D. ;   et al.
2022-06-02
Heteroaryl-substituted triazoles as APJ receptor agonists
Grant 11,046,680 - Chen , et al. June 29, 2
2021-06-29
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20210179560 - Bartberger; Michael D. ;   et al.
2021-06-17
Triazole furan compounds as agonists of the APJ receptor
Grant 10,736,883 - Brown , et al. A
2020-08-11
Triazole Furan Compounds As Agonists Of The Apj Receptor
App 20190275008 - BROWN; Matthew ;   et al.
2019-09-12
Triazole agonists of the APJ receptor
Grant 10,221,162 - Chen , et al.
2019-03-05
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20190062276 - Bartberger; Michael D. ;   et al.
2019-02-28
Triazole Agonists Of The Apj Receptor
App 20180319773 - CHEN; Ning ;   et al.
2018-11-08
Triazole agonists of the APJ receptor
Grant 9,868,721 - Chen , et al. January 16, 2
2018-01-16
Intermediates for preparing triazole agonists of the APJ receptor
Grant 9,845,310 - Chen , et al. December 19, 2
2017-12-19
Methods for preparing triazole agonists of the APJ receptor
Grant 9,751,864 - Chen , et al. September 5, 2
2017-09-05
Triazole agonists of the APJ receptor
Grant 9,745,286 - Chen , et al. August 29, 2
2017-08-29
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20170144971 - BARTBERGER; Michael D. ;   et al.
2017-05-25
Intermediates for preparing triazole agonists of the APJ receptor
Grant 9,656,998 - Chen , et al. May 23, 2
2017-05-23
Triazole agonists of the APJ receptor
Grant 9,656,997 - Chen , et al. May 23, 2
2017-05-23
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
Grant 9,593,129 - Bartberger , et al. March 14, 2
2017-03-14
Triazole agonists of the APJ receptor
Grant 9,573,936 - Chen , et al. February 21, 2
2017-02-21
Triazole Agonists Of The Apj Receptor
App 20170044131 - CHEN; Ning ;   et al.
2017-02-16
Triazole Agonists Of The Apj Receptor
App 20170042897 - Chen; Ning ;   et al.
2017-02-16
Triazole Agonists Of The Apj Receptor
App 20170042872 - CHEN; Ning ;   et al.
2017-02-16
Triazole Agonists Of The Apj Receptor
App 20170042871 - Chen; Ning ;   et al.
2017-02-16
Triazole Agonists Of The Apj Receptor
App 20170035744 - CHEN; Ning ;   et al.
2017-02-09
Triazole Agonists Of The Apj Receptor
App 20170037026 - CHEN; Ning ;   et al.
2017-02-09
Triazole Agonists Of The Apj Receptor
App 20160340336 - Chen; Ning ;   et al.
2016-11-24
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
Grant 9,376,425 - Bartberger , et al. June 28, 2
2016-06-28
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
App 20160137667 - BARTBERGER; Michael D. ;   et al.
2016-05-19
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
Grant 9,296,736 - Bartberger , et al. March 29, 2
2016-03-29
Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
Grant 8,980,903 - Connors , et al. March 17, 2
2015-03-17
Fused Pyridine, Pyrimidine And Triazine Compounds As Cell Cycle Inhibitors
App 20140350244 - Connors; Richard V. ;   et al.
2014-11-27
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer
App 20140315895 - Bartberger; Michael D. ;   et al.
2014-10-23
Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
Grant 8,841,312 - Connors , et al. September 23, 2
2014-09-23
Heterocyclic Compounds As Mdm2 Inhibitors For The Treatment Of Cancer
App 20140235629 - Bartberger; Michael D. ;   et al.
2014-08-21
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer
App 20140011796 - BARTBERGER; Michael David ;   et al.
2014-01-09
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer
App 20110319378 - BARTBERGER; Michael David ;   et al.
2011-12-29
Fused Pyridine, Pyrimidine and Triazine Compounds as Cell Cycle Inhibitors
App 20110142796 - Connors; Richard V. ;   et al.
2011-06-16
Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
Grant 7,939,538 - Fu , et al. May 10, 2
2011-05-10
Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disorders
Grant 7,799,795 - Bergeron , et al. September 21, 2
2010-09-21
Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use
Grant 7,375,102 - Fu , et al. May 20, 2
2008-05-20
Imidazolo-related compounds, compositions and methods for their use
Grant 7,271,271 - Fu , et al. September 18, 2
2007-09-18
Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disorders
App 20070015773 - Bergeron; Philippe ;   et al.
2007-01-18
Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
App 20060069099 - Fu; Zice ;   et al.
2006-03-30
Imidazolo-related compounds, compositions and methods for their use
App 20060069127 - Fu; Zice ;   et al.
2006-03-30
Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use
App 20060069106 - Fu; Zice ;   et al.
2006-03-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed